Groowe Groowe / Newsroom / VERU
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

VERU News

Veru Inc.

Chronic Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Domain | DelveInsight

globenewswire.com
TLRY TAK TNDM NVS BMY PFE INCY JNJ AZN MRK ABBV CRSP SCLX RIGL JAZZ GILD REGN AMGN BIIB PTGX EXAS SNOW SRPT VRTX BNTX ALKS RGEN IMUX ADPT ATRC CRNX CYTK DTIL EXEL FGEN GALT GNTX GRFS GSK HRMY IDXX ILMN INSM IONS IRWD KODK LAKE LULU LYFT MAR MDLZ MELI MIRM MNKD MRNA MTCH NBIX NCLH NEM NTRA NVCR ODFL OMER ORGO OTEX PACB PBYI PCAR PEGA PERI PETS PLRX PMVP PPC PRGS PRTA PSNL PTN PZZA QGEN QTRX RARE RCEL RDHL RLAY RLGT RMD ROST RRX RYAAY RYTM SAN SBAC SBRA SEIC SIGA SIRI SITE SLAB SLGN SMCI SMMT SNPS SNY SOFI SONO SPCE SSYS STNG STRA STRL STX SWKS SYK SYNA TCOM TDOC TECK TEVA TFX TGTX TIGR TRMB TRVG TTWO TUSK TXRH ULTA UMC UNFI UNH URBN UTHR VEEV VELO VERU VIVO VKTX VLRS VNDA VRSK VSAT VTGN WDC WEC WERN WGO WIX WMB WST WTW WYNN XOM XPER XPO XRAY YETI YRD YUM ZBRA ZLAB ZYME

Form 8-K

sec.gov
VERU

Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ RASONQUE™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial

globenewswire.com
VERU

Veru to Participate in Fireside Chat at the 2026 Cantor Global Healthcare Conference

globenewswire.com
VERU

Form 8-K

sec.gov
VERU

Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress

globenewswire.com
VERU

Veru Announces Notice of Allowance for Key Methods of Use U.S. Patent for Enobosarm in Combination with Semaglutide for Quality Weight Loss

globenewswire.com
VERU

Veru to Report Fiscal 2026 Third Quarter Financial Results on August 10th

globenewswire.com
VERU

Veru to Participate in Fireside Chat at the Canaccord Genuity's 46th Annual Growth Investors Conference

globenewswire.com
VERU

Veru Announces Full Enrollment for Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss

globenewswire.com
VERU